Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 71 Lung Neoplasms 32 Triple Negative Breast Neoplasms 23 Breast Neoplasms 19 Small Cell Lung Carcinoma 15 Ovarian Neoplasms 15 Squamous Cell Carcinoma of Head and Neck 13 Endometrial Neoplasms 13 Neoplasms 12 Parkinson Disease 4, Autosomal Dominant Lewy Body 10 Fallopian Tube Neoplasms 10 Neoplasm Metastasis 9 Colorectal Neoplasms 6 Urinary Bladder Neoplasms 5 Carcinoma 5 Adenocarcinoma of Lung 5 Esophageal Neoplasms 4 Uterine Cervical Neoplasms 3 Pathologic Complete Response 3 Pancreatic Neoplasms 3 Oropharyngeal Neoplasms 3 Mesothelioma 3 Melanoma 3 Lung Diseases 3 Head and Neck Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Central Nervous System Neoplasms 3 Uterine Neoplasms 2 Thoracic Neoplasms 2 Sarcoma 2

Interventions

pembrolizumab 1 cemiplimab 1 Pemetrexed 1 Cisplatin 1 Carboplatin 1 Axitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Non-small Cell Lung Cancer × Carboplatin × 30 days × Clear all

NCT06452277 2026-05-18

SOHO-02

Bayer

Phase 3 Recruiting

Advanced Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡